BDBM50121975 (6-Methoxy-quinolin-4-yl)-(5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol::CARDIOQUIN::CHEMBL1294::CIN-QUIN::DURAQUIN::QUINACT::QUINAGLUTE::QUINALAN::QUINATIME::QUINIDEX::QUINIDINE::QUINORA::US9402878, Quinidine
SMILES COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1
InChI Key InChIKey=LOUPRKONTZGTKE-LHHVKLHASA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 50121975
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Novobiotic Pharmaceuticals
US Patent
Novobiotic Pharmaceuticals
US Patent
Affinity DataIC50: 1.44E+3nMpH: 7.0Assay Description:Briefly, the experiments were performed on an IonWorks™ HT instrument (Molecular Devices Corporation), which automatically performs electrophys...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Novobiotic Pharmaceuticals
US Patent
Novobiotic Pharmaceuticals
US Patent
Affinity DataIC50: 2.67E+3nMAssay Description:Inhibition of human ERG expressed in CHO cells by patch plate methodMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Novobiotic Pharmaceuticals
US Patent
Novobiotic Pharmaceuticals
US Patent
Affinity DataIC50: 324nMAssay Description:Inhibition of human Potassium channel HERG expressed in mammalian cellsMore data for this Ligand-Target Pair